Harmony Biosciences Holdings, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 CERE
|
Cerevel Therapeutics Holdings, Inc. | $44.96 | $7.29 B | -14.66 | 355 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $28.40 | $1.65 B | -11.47 | 97 | $0 |
 FENC
|
Fennec Pharmaceuticals Inc. | $4.62 | $187.43 M | 171.5 | 29 | $21.64 M |
 GOSS
|
Gossamer Bio, Inc. | $1.07 | $124.06 M | -0.65 | 135 | $0 |
 GPCR
|
Structure Therapeutics Inc. | $43.08 | $2.47 B | -23.59 | 136 | $0 |
 IDYA
|
IDEAYA Biosciences, Inc. | $29.97 | $2.88 B | -19 | 124 | $23.39 M |
 INZY
|
Inozyme Pharma, Inc. | $5.17 | $286.39 M | -3.43 | 59 | $0 |
 JANX
|
Janux Therapeutics, Inc. | $44.94 | $2.29 B | -36.8 | 69 | $8.08 M |
 KRON
|
Kronos Bio, Inc. | $0.97 | $44.62 M | -0.37 | 58 | $6.29 M |
 KROS
|
Keros Therapeutics, Inc. | $61.06 | $1.76 B | -9.45 | 149 | $151,000 |
 LYRA
|
Lyra Therapeutics, Inc. | $0.24 | $19.53 M | -0.27 | 88 | $1.56 M |
 NUVL
|
Nuvalent, Inc. | $105.09 | $5.11 B | -32.72 | 115 | $0 |
 NVCT
|
Nuvectis Pharma, Inc. | $6.10 | $116.38 M | -4.5 | 13 | $0 |
 PLRX
|
Pliant Therapeutics, Inc. | $11.53 | $672.63 M | -3.9 | 166 | $1.58 M |
 PTGX
|
Protagonist Therapeutics, Inc. | $44.38 | $2.04 B | 13.7 | 125 | $60.00 M |
 REPL
|
Replimune Group, Inc. | $11.48 | $485.18 M | -2.44 | 331 | $0 |
 RVMD
|
Revolution Medicines, Inc. | $47.31 | $6.66 B | -10.51 | 443 | $11.58 M |
 SNDX
|
Syndax Pharmaceuticals, Inc. | $18.82 | $1.66 B | -6.02 | 184 | $0 |
 TVTX
|
Travere Therapeutics, Inc. | $15.23 | $542.80 M | -1.32 | 380 | $145.24 M |
 VRDN
|
Viridian Therapeutics, Inc. | $23.87 | $776.72 M | -2.71 | 94 | $314,000 |
 VRNA
|
Verona Pharma plc | $31.80 | $983.52 M | -15.16 | 79 | $0 |
 VTYX
|
Ventyx Biosciences, Inc. | $2.12 | $229.83 M | -1.01 | 73 | $0 |